Julie Mchugh is a Board Member at Xellia. Julie has also previously served as the Chief Operating Officer at Endo Pharmaceuticals, Company Group Chairman, Virology at Johnson & Johnson, and President at Centocor. Ms. Mchugh has also been a Member of the Board at EPIRUS Biopharmaceuticals, Trevena, Inc, and Ironwood Pharmaceuticals.
Julie Mchugh has a Bachelor of Science in Finance from Penn State University and a Master of Business Administration in International Business from Saint Joseph's University.
Current role